.svg){kind=icon}
Two cannabis products can contain similar amounts of THC and still feel very different depending on how they are administered.
One reason is pharmacokinetics—the way cannabinoids are absorbed, distributed, metabolized, and eliminated by the body.
For medical cannabis patients, two especially useful concepts are:
Onset: How long it takes before effects begin.
Duration: How long those effects may persist.
These are not the same thing.
A route with a rapid onset may have a relatively short duration, while a slower route may produce effects that last considerably longer.
Understanding that difference can help patients avoid common dosing mistakes, especially taking an additional dose before the first dose has fully developed.
Why Route of Administration Matters
Cannabinoids must enter the body before they can produce systemic effects.
The path they take depends on the product.
Cannabis may be:
- Inhaled
- Swallowed
- Used in the mouth or under the tongue
- Applied to the skin
Each route exposes cannabinoids to different biological processes.
Inhaled cannabinoids move rapidly from the lungs into circulation.
Swallowed cannabinoids pass through the digestive tract and liver.
Oromucosal products may be partly absorbed through oral tissues and partly swallowed.
Skin-applied products may remain primarily localized or, if specifically formulated as transdermal systems, may be designed for systemic absorption.
These differences change both onset and duration.
A Simple Comparison
Approximate timing ranges are useful for education, but they should never be treated as guarantees.
RouteApproximate OnsetTypical DurationInhaledMinutesAbout 2–4 hoursOral / edible30 minutes to 2+ hoursAbout 6–8 hours, sometimes longerOromucosal / sublingualAbout 15–60 minutesOften several hoursTopicalVariable; primarily localProduct dependentTransdermalFormulation dependentMay provide prolonged delivery
Individual responses can fall outside these ranges.
Dose, formulation, tolerance, food, medications, metabolism, and product design can all affect timing.
Inhalation: Fast Onset, Shorter Duration
Smoking and vaporization deliver cannabinoids through the lungs.
The lungs have a large surface area and extensive blood supply, allowing THC and other cannabinoids to enter circulation rapidly.
Blood concentrations can rise within minutes.
Patients may therefore notice effects relatively quickly compared with oral administration.
This fast feedback can make inhaled cannabis easier to evaluate in the moment.
However, inhalation is not necessarily easy to dose precisely.
The cannabinoid amount delivered by a puff can depend on:
- Puff duration
- Device temperature
- Airflow
- Product concentration
- Inhalation volume
- Device efficiency
So while onset may be rapid, “one puff” is not a standardized medical dose.
Why Inhaled Effects Do Not Last as Long
Inhaled THC reaches circulation quickly and also begins redistributing through the body relatively quickly.
The noticeable effects therefore tend to have a shorter duration than swallowed THC.
For many patients, inhaled effects may persist for several hours rather than most of the day.
That does not mean impairment always disappears at a precise time.
Dose and individual response still matter.
Patients should avoid driving or performing safety-sensitive activities while impaired.
Oral Cannabis: Slower and More Variable
Edibles, capsules, tablets, and swallowed oils take a different route.
Before cannabinoids reach systemic circulation, they must move through the gastrointestinal tract.
This introduces several variables:
- Gastric emptying
- Food intake
- Product formulation
- Digestive absorption
- Liver metabolism
- Individual metabolic differences
As a result, oral cannabis generally has a slower and less predictable onset than inhalation.
A patient may begin noticing effects within 30 to 60 minutes, while another may require two hours or longer.
Why Oral THC Can Last Longer
After THC is absorbed from the digestive tract, it travels through the liver before reaching systemic circulation.
This is known as first-pass metabolism.
The liver converts some THC into metabolites including 11-hydroxy-THC, which is also psychoactive.
This contributes to the distinctive pharmacokinetics of oral THC.
The result is usually:
slower onset
but
longer duration.
For some patients, effects from an oral product may persist for six to eight hours or potentially longer depending on dose.
The Redosing Problem
Delayed onset creates one of the most important cannabis-safety issues.
A patient takes an edible.
After 30 minutes, little seems to be happening.
The patient assumes the dose was insufficient and takes another serving.
The first dose then begins producing stronger effects.
Shortly afterward, the second dose begins contributing as well.
The result may be substantially more THC exposure than intended.
This is why oral products require patience.
The absence of immediate effects does not necessarily mean the first dose was ineffective.
Peak Effect Is Different From Onset
Another important concept is peak effect.
Onset answers:
When do I first notice something?
Peak answers:
When might the effects be strongest?
These can occur at very different times.
With inhalation, both onset and peak tend to occur relatively quickly.
With oral THC, effects may start gradually but continue building for several hours.
Patients should therefore avoid interpreting the first detectable sensation as the maximum effect of an edible.
What About Sublingual Tinctures?
“Sublingual” means under the tongue.
The idea is that cannabinoids may be absorbed through tissues in the mouth rather than traveling entirely through the gastrointestinal tract.
In practice, the situation is more complicated.
Some of a tincture may be absorbed through oral tissues.
Some may be swallowed.
The swallowed portion then behaves more like an oral cannabinoid product.
Research using standardized oromucosal cannabis medicines suggests onset may occur faster than conventional swallowed products, but absorption still varies.
Patients should therefore follow the instructions for the specific tincture rather than assuming every liquid cannabis product begins working immediately.
Holding a Tincture Longer Does Not Guarantee a Specific Dose
Patients sometimes assume that keeping oil under the tongue for an exact number of seconds guarantees sublingual absorption.
Human pharmacokinetics are not that precise.
Variables include:
- Formulation
- Carrier oil
- Cannabinoid concentration
- Oral tissue contact
- Saliva
- Amount eventually swallowed
A measured milliliter still tells patients how much product was administered, but it does not guarantee how much entered circulation through each pathway.
Conventional vs. Fast-Acting Edibles
Some modern edible formulations are marketed as fast acting.
These formulations may use technologies intended to improve cannabinoid dispersion or absorption.
Their timing should not automatically be assumed to match either conventional edibles or inhalation.
Patients should use the specific product label and physician guidance when evaluating expected onset.
A “fast-acting” label should not be interpreted as permission to redose immediately.
Topical Cannabis Is Different
Topical cannabis products are applied to the skin.
Examples include:
- Lotions
- Balms
- Creams
- Salves
These products are generally designed for application to a specific area rather than to create the same systemic cannabinoid exposure associated with inhalation or oral ingestion.
That makes the usual oral-versus-inhaled onset comparison less useful.
Cannabinoids also cross skin inefficiently without specialized formulation technology.
Patients should therefore not assume that applying a THC topical is pharmacokinetically equivalent to taking an edible.
Topical and Transdermal Are Not the Same
This distinction is frequently overlooked.
A topical formulation is generally intended to act primarily where it is applied.
A transdermal formulation is designed to move active compounds through the skin into systemic circulation.
Transdermal drug delivery often requires specialized formulation because cannabinoids are highly lipophilic and do not easily cross all layers of the skin.
Research into cannabinoid transdermal delivery continues, but human pharmacokinetic evidence is still much less developed than the evidence for inhaled and oral THC.
Duration Does Not Equal Impairment Time
Another important distinction is the difference between:
how long a patient notices effects
and
how long impairment may remain relevant.
A person may no longer feel strongly intoxicated while still experiencing changes in:
- Reaction time
- Attention
- Coordination
- Judgment
This is particularly relevant with higher THC doses and longer-acting oral formulations.
Patients should use conservative judgment around driving and other safety-sensitive activities.
Dose Still Matters
Route does not replace dose.
Consider two oral THC products:
2.5 mg THC
and
20 mg THC
Both use the same administration route.
But their intensity and duration may be very different.
Likewise, a small inhaled exposure and repeated inhalations from a high-potency concentrate should not be expected to produce the same timeline.
The complete dosing picture includes:
milligrams + route + formulation + timing + individual response
Green Dragon Florida Route Examples
These products demonstrate different administration formats rather than representing recommendations for particular symptoms.
Old Pal Purple Martian Cartridge — Titusville
Old Pal Purple Martian Cartridge is currently listed as a 1-gram vaporizer cartridge at approximately 88.6% THC.
A vaporizer illustrates the inhaled route, where cannabinoid absorption generally occurs rapidly.
However, the amount delivered by an individual puff varies, so patients should not treat puff count as a standardized milligram measurement.
Green Dragon Cloudberry Fast-Acting Chews — Tampa
Green Dragon Cloudberry Fast-Acting Chews are currently listed as a 100 mg THC package.
This product illustrates an oral formulation marketed as fast acting.
Patients should still distinguish the cannabinoid amount in an individual serving from the total package and follow the specific product instructions before considering another dose.
Le Remedie Extra Strength THC Lotion — Tampa
Le Remedie Extra Strength THC Lotion is currently listed as a 5-ounce topical containing 450 mg THC.
This provides a useful example of why product cannabinoid content alone does not determine systemic dose.
A skin-applied topical and a 450 mg oral formulation would have completely different pharmacokinetic expectations.
Product availability and laboratory values may change by Green Dragon Florida location.
The Green Dragon Takeaway
When discussing medical cannabis, onset and duration are not interchangeable.
Inhalation generally offers the fastest onset and a shorter duration.
Oral products generally take longer to begin but can last considerably longer.
Oromucosal products fall somewhere between these routes, depending on how much is absorbed through oral tissues versus swallowed.
Topical and transdermal products require another set of pharmacokinetic considerations and should not be grouped together automatically.
For patients, the practical questions are:
How much cannabinoid am I using?
How is it being administered?
How long should I allow before evaluating the response?
How long could the effects persist?
Understanding those questions can make medical cannabis dosing more consistent and help reduce premature redosing.